Cargando…
Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
Combination immunotherapy has emerged as a promising strategy to increase the immune response in glioblastoma (GBM) and overcome the complex immunosuppression occurring in its microenvironment. In this study, we hypothesized that combining DNA vaccines—to stimulate a specific immune response—and dua...
Autores principales: | Bausart, Mathilde, Vanvarenberg, Kevin, Ucakar, Bernard, Lopes, Alessandra, Vandermeulen, Gaëlle, Malfanti, Alessio, Préat, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145362/ https://www.ncbi.nlm.nih.gov/pubmed/35631612 http://dx.doi.org/10.3390/pharmaceutics14051025 |
Ejemplares similares
-
New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models
por: Lopes, Alessandra, et al.
Publicado: (2021) -
Immunotherapy for glioblastoma: the promise of combination strategies
por: Bausart, Mathilde, et al.
Publicado: (2022) -
Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma
por: Kos, Spela, et al.
Publicado: (2019) -
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
por: Lopes, Alessandra, et al.
Publicado: (2018) -
Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma
por: Malfanti, Alessio, et al.
Publicado: (2022)